Variant report
Variant | esv3462769 |
---|---|
Chromosome Location | chr3:159180439-159183523 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549942209 | chr3:159180499-159180500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs140133695 | chr3:159180514-159180515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538805405 | chr3:159180527-159180528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554192933 | chr3:159180543-159180544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527711019 | chr3:159180584-159180585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181453885 | chr3:159180591-159180592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1489920 | chr3:159180640-159180641 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs1489921 | chr3:159180660-159180661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116162817 | chr3:159180700-159180701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564772602 | chr3:159180713-159180714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576723868 | chr3:159180725-159180726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185375739 | chr3:159180732-159180733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540776671 | chr3:159180787-159180788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145423234 | chr3:159180824-159180825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527908619 | chr3:159180844-159180845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543271666 | chr3:159180928-159180929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540488808 | chr3:159180984-159180985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs189844576 | chr3:159180998-159180999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539200524 | chr3:159181023-159181024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369873372 | chr3:159181068-159181069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550447583 | chr3:159181069-159181070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571556308 | chr3:159181070-159181071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532527643 | chr3:159181071-159181072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs149211161 | chr3:159181079-159181080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539996159 | chr3:159181080-159181081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs571093691 | chr3:159181163-159181164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs11710233 | chr3:159181179-159181180 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs536315914 | chr3:159181299-159181300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs180890861 | chr3:159181329-159181330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145117873 | chr3:159181347-159181348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs568633168 | chr3:159181379-159181380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184960697 | chr3:159181403-159181404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558807361 | chr3:159181404-159181405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576799035 | chr3:159181416-159181417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs191967125 | chr3:159181446-159181447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs183883551 | chr3:159181475-159181476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574600271 | chr3:159181496-159181497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188550344 | chr3:159181522-159181523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143494695 | chr3:159181530-159181531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs72428056 | chr3:159181531-159181532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs567805478 | chr3:159181535-159181536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150115516 | chr3:159181537-159181538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138878042 | chr3:159181538-159181539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34792064 | chr3:159181547-159181548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs191850327 | chr3:159181575-159181576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs55890723 | chr3:159182407-159182408 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs544351 | chr3:159182419-159182420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543971745 | chr3:159182436-159182437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565306341 | chr3:159182462-159182463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560199685 | chr3:159182463-159182464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 21509527 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:159177400-159181600 | Weak transcription | Osteobl | bone |
2 | chr3:159182400-159183000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr3:159182400-159183000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr3:159182400-159183200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
5 | chr3:159182400-159185200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr3:159183000-159184200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |